Dynamic changes in pH during cell division hold clues for cancer, Notre Dame researchers show
Scientists have known that the pH within cancer cells is generally higher than the pH within non-cancerous ones.
This increase in pH allows cancer cells to grow and divide more successfully, but previous studies were conducted using populations of thousands or tens of thousands of cells that could be in various stages of cell division.
A new study in the Journal of Cell Science by University of Notre Dame researchers examined individual cells instead, and showed that cancer cells have a higher pH than normal cells, but discovered that single-cell pH changes dynamically during the four phases of cell division. This discovery could eventually lead to therapies that will limit cancer cells’ ability to grow and divide.
Julia Spear, a doctoral student in the Integrated Biomedical Sciences program in the lab of Katharine White, the Clare Luce Booth Assistant Professor in the Department of Chemistry and Biochemistry, completed the research using normal and cancerous human lung cells and manipulating their pH to determine how they progressed through the cell cycle.
“Julia’s paper really adds on a significant understanding of what’s going on at the single- cell level,” said White, who is affiliated with Harper Cancer Research Institute. “There are big questions about where and when pH changes are happening during cell division and whether those changes are required or sufficient for cell division.”
[Watch as a single cell progresses through the cell cycle and divides into two daughter cells.]
White and Spear knew that pH dynamics within cells—intracellular pH (pHi)—signal them to start migrating or dividing. At the population level, previous research showed that preventing cells from having higher pH can delay division, but the mechanisms or reasons for this outcome were unclear.
Spear found that single-cell pH decreases when a cell decides to initiate the process of cell growth and division, but increases during the middle of the phase where each of the 23 chromosomes are duplicated. Later in that phase, however, pH decreases again, and increases just before the cell condenses its chromosomes for division. During the final phase of division, however, as the duplicated chromosomes separate into daughter cells, pH rapidly decreases again.
“Julia showed that increased pHi led to more successful division and that lowering pH in the cells really did suggest that if she was able to lower pH anywhere during the process, regardless of the actual raw value of pH, cells would have difficulty dividing,” White said.
Taken together, Spear’s data suggests lowering pH in cancer cells may block cancer cell division and growth. However, lowering pH of all cells in the body for cancer treatment simply is not an option, which has been a sticking point in targeting pH for cancer treatment.
“One of the issues is that most of those pH-lowering drugs fail in clinical trials because lowering pH damages very important tissues - your kidneys and heart,” White said. “This is why understanding the effects of increased pH is so important. It allows us to design drugs that target the underlying pH-dependent behavior.”
Understanding where the pH changes occur during cell division may someday help clinicians better treat the cells at the stage where lowering their pH would have the most benefit, Spear said.
Up next: The team is creating an experiment to find out which proteins sense the pH dynamics and shepherd the transitions between the phases of cell division, because that is one area the paper was not able to address.
Spear said she is excited to continue the fundamental research into the process of cancer cell division.
“While I’m not the one curing cancer, I’m showing the fundamentals of where and when pH changes might be important,” she said. “Then I’m giving someone else in the lab that data so they can identify the proteins to go after.”
The research was funded by an NIH Director’s New Innovator Award (DP2-DP2CA260416).
Originally published by science.nd.edu on June 05, 2023.
atLatest Research
- Senator Todd Young and NSF Director Sethuraman Panchanathan visit Notre Dame to discuss critical investments in science and technologyOn Thursday, April 25, Sethuraman Panchanathan, director of U.S. National Science Foundation (NSF), joined U.S. Senator Todd Young in a visit to the campus of the University of Notre Dame. The pair met with faculty, students, and University leaders and discussed how research and innovation can drive…
- White House’s Jake Braun addresses statewide cybersecurity summit at Notre DameOn April 18, 2024, leaders in cybersecurity from government, industry, and academia gathered for the 2024 Indiana Statewide Cybersecurity Summit hosted by the University of Notre Dame in collaboration with co-sponsors Indiana University, Purdue University,…
- Hauenstein, Putman named as Simons FellowsTwo University of Notre Dame professors were named fellows of the Simons Foundation for 2024, which will allow them the opportunity to intensely focus on their research for up to a year. Jonathan…
- Literacy scholar Ernest Morrell elected to American Academy of Arts & SciencesErnest Morrell, the Coyle Professor of Literacy Education at the University of Notre Dame, has been elected to the American Academy of Arts and Sciences, one of the nation’s oldest learned societies and independent policy research centers. Morrell was one of the 250 members of the newest AAAS class announced today. Other notable names among the group include filmmaker George Clooney, Apple CEO Tim Cook, novelist Jhumpa Lahiri, and Pulitzer Prize-winning New York Times columnist and 1993 Notre Dame alumnus Carlos Lozada.
- Notre Dame faculty fight malaria resurgence in BangladeshBetween 2008 and 2020, districts across the country of Bangladesh saw a 93% reduction in malaria cases. Today, as the world reflects on the World…
- Anthropologist's research shows there’s no ‘one size fits all’ when it comes to addressing men’s health issues globallyAt a time when health resources are at a premium and need to be wisely allocated, health professionals must find points within men’s lives when it makes the most sense to intervene and advocate for preventive care for promoting better health outcomes. Life transitions such as marriage and fatherhood are often pivotal and crucial intervention points. But just like every man is different, health concerns across global communities differ as well. Research from the University of Notre Dame finds that not all life transitions produce the same health results, and not all men’s global health policies should look the same from one country to another.